Navigation Links
Tamoxifen Helps Treat Bipolar Disorder
Date:9/12/2007

Discovery may lead to new drug to treat manic phase of the illness, study says

WEDNESDAY, Sept. 12 (HealthDay News) -- The breast cancer drug tamoxifen helps control the manic phase of bipolar disorder, and works faster than many standard medications used to treat the chronic mental illness, a new study has found.

"One of the problems with existing treatments for bipolar disorder is they seem to have this long period before they start to work," explained Dr. Husseini K. Manji, senior study author and director of the U.S. National Institute of Mental Health's mood and anxiety disorders program.

Current treatments sometimes take weeks to become effective, Manji said. "And that obviously creates a huge problem," he said. When patients are in the manic phase, particularly, not getting relief fast enough from medication may mean they need to be hospitalized, he noted.

For the study, Manji and his colleagues gave eight patients experiencing a manic episode tamoxifen, while another eight received a placebo; no one knew which drug they were getting. After three weeks, 63 percent of those on tamoxifen had reduced symptoms of mania, compared to just 13 percent of those on a placebo. The tamoxifen group responded by the fifth day of treatment.

The study results are published online in the September issue of Bipolar Disorders.

Manji and his colleagues decided to study tamoxifen because they knew that standard medications used to treat mania are known to lower the activity of an enzyme called protein kinase C, or PKC, that regulates activities in brain cells. This enzyme is believed to become overactive when bipolar disorder patients experience a manic episode.

Tamoxifen also blocks PKC, but does it more directly than some bipolar drugs, according to the researchers.

Manji and his team made the discovery after years of searching for the correct cellular target to treat bipolar diso
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Letrozole Beats Tamoxifen in Breast Cancer Therapy
2. Tamoxifen does not adversely affect the brain
3. Tamoxifen reduces breast cancer risk
4. Tamoxifen reduces breast cancer risk
5. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
6. Tamoxifen Ineffective In Presence Of Genetic Variation in Breast Cancer
7. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
8. Raloxifene Better Than Tamoxifen For Breast Cancer
9. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
10. Study Identifies Mechanism Which May Help Tamoxifen Work Better
11. Tamoxifen Discontinuation Rates Surprisingly High
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...KANSAS CITY, Kan., Jan. 7 The Leuk...ity of Kansas Cancer Center have announced a part...earchers into Phase I clinical trials. , , Curr...U Cancer Center) and its partner, Beckloff Associa...of LLS-funded researchers at The University of Vi...
(Date:1/7/2009)...7 Zimmer Holdings, Inc.,...be participating in the 27th,Annual JP Morgan Hea... 2009,at 12:00 p.m. Eastern Time. , A liv...Zimmer,s Investor,Relations website at http://in...,for replay following the conference. , A...
(Date:1/7/2009)...ff 2009 with Mission Trips to Developing Countries...e-USNewswire/ -- Parents of a child born with clef...ion, to make sure their child lives a normal life....uilding on a tradition of volunteering and philant...Surgeons (ASPS) will usher in 2009 by demonstratin...
(Date:1/7/2009)... members save on ice skating admission , , PHI... Blue Cross (IBC) is encouraging families to atten... 11, 2009, at the Blue Cross RiverRink at Penn,s L...se New Year,s resolutions, the celebration of fun ... for the whole family. , , The Blue Cross River...
Breaking Medicine News(10 mins):Health News:The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development 2Health News:The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development 3Health News:New Year Brings New Hope to Children Born With Cleft Lip, Palate 2Health News:New Year Brings New Hope to Children Born With Cleft Lip, Palate 3Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2
...den of crystalline methamphetamine ("ice" or "crys... public hospital resources is significant and set ...have warned in the latest Medical Journal of Austr...l to beef up health and social drug intervention s...
...nd morbidly obese coronary patients are more likel...heart surgery//, according to cardiothoracic surge...ic surgery registrar from St Vincent's hospital in...tients having coronary artery bypass grafting or h...
...hi, Films showing actors blowing glorious rings of... be out of reach for those below 18 years//. An a...s fight against tobacco consumption has suggested ...scenes should be awarded an 'A' (adult) certificat...
...mericans in the US are increasingly opting for pla...ucusian//. The pressure to alter one's features a...c community in America, observers say. But the min... According to a survey by the American Society of...
Other Medicine News:Health News:Emergency Department Strain As Ice Problems Grows 2Health News:Emergency Department Strain As Ice Problems Grows 3Health News:Obese Heart Patients At Greater Risk 2Health News:Indian Films With Smoking Scenes may Get 'A' Certificate 2Health News:Asians in US Increasingly Undergoing Plastic Surgery to Look White 2
(Date:1/3/2009)... , , , , ROSEMONT, Ill., Jan. ...aging (MRI) is a growing technology providing an i... the evaluation of back pain according to an artic... American Academy of Orthopaedic Surgeons ( http:/...next several years, additional technical developme...
(Date:12/27/2008)... Brigitte Boisselier breaks 5-year silence, offers... to go public , , LAS VEGAS, Dec. 27 /PRNewswir...rth of Baby Eve, the first cloned child, Dr. Brigi... Clonaid project, said Eve and other babies cloned...- and with no one invading their families, privacy...
(Date:12/17/2008)... FRANCISCO, Dec. 17 Medi...at it has completed patient enrollment in a,Phase...s novel androgen,receptor antagonist, in castrati...t will seek approval from the U.S. Food and Drug A...l trials next year. , The open-label, U.S. ...
(Date:12/16/2008)...earch Uncovers New Link Between Inflammation &...c. 16 The Roskamp Institute today ...w link between inflammation and Alzheimer,s diseas...oping novel therapeutics for intervention in this ...ncham Bakshi, Ph.D., is detailed in the American ...
Breaking Medicine Technology:MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3'We're Ready to Prove It!' 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 1Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 2Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 3Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 4Mayo Clinic to Pilot Collexis Expert Profiling 684 1Mayo Clinic to Pilot Collexis Expert Profiling 684 2Mayo Clinic to Pilot Collexis Expert Profiling 684 3Award winning QUITPLAN 28R 29 Services Billboard Debuts in Rogers 679 1Award winning QUITPLAN 28R 29 Services Billboard Debuts in Rogers 679 2Stryker To Host Conference Call on October 17 2007 674 1Stryker To Host Conference Call on October 17 2007 674 2
...CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 24, 2007 - ...l company that develops targeted,anticancer therap...hnology, today announced that clinical findings fo...of solid tumors are to be,reported at the 43rd Ame...eeting to take place June 1-5, 2007 in Chicago, IL...
... BERKELEY HEIGHTS, N.J., May 25, 2007 /PRNewswire-...veral abstracts featuring its,oncology products, G...ite(R) (gallium nitrate injection), will be presen...iety of Clinical Oncology,(ASCO) in Chicago, June ..., -- LDH is a Prognostic Factor in Stage IV Mel...
Other Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3Genta Incorporated to Present Multiple Abstracts at the Annual,Meeting of the American Society of Clinical Oncology 2Genta Incorporated to Present Multiple Abstracts at the Annual,Meeting of the American Society of Clinical Oncology 3
... product line has the right product for any patien...ated patients to patients with tracheotomies. Thes...anesthesia and critical care applications., ,The ...ection for patients and staff members. This entire...
Passive heat and moisture exchangers for respiratory applications.
Ballard trach care HMES and filters, tv1000, HME
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours
Medicine Products: